Answers are grounded in this paper and cite their sources.
Polyisobutylene based block copolymers have attracted significant interest for biomedical applications. Poly(styrene‐ b ‐isobutylene‐ b ‐styrene) (SIBS) has been used as a drug (Paclitaxel, PTx) eluting coating for the TAXUS™ stent. By changing the polarity of the end segments modulation of drug release has been achieved. In this paper, two new synthetic routes are reported for the synthesis of polyisobutylene (PIB) based block copolymers containing poly(methyl methacrylates) end blocks by the combination of living cationic and anionic polymerizations. In the first approach the PIB chain‐ends were converted to macroanions that efficiently initiated the polymerization of methacrylates in tetrahydrofuran (THF) at −78 °C to afford poly(isobutylene‐ b ‐methyl methacrylate) (PIB‐ b ‐PMMA). PIB‐ b ‐PMMA could also be synthesized by a coupling reaction between living poly(methacrylate) anion and bromoallyl end‐functional PIB.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: